- Shares of Electromed (ELMD +110.9%) are on their way to a banner session on the heels of FDA marketing clearance for SmartVest SQL.
- The SQL is "smaller, quieter, and lighter" than previous versions, the company notes.
- ELMD says the device should be available in the U.S. "within the next 60 days." (PR)
Electromed doubles on marketing clearance for new SmartVest model
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs